The national competition watchdog raises competition issues.
The Australian Competition and Consumer Commission (ACCC) has expressed preliminary concerns about Sigma Healthcare Limited’s proposed acquisition of Chemist Warehouse Group Holdings.
In a Statement of Issues released today, the ACCC outlined potential competition problems.
“This is a significant structural change for the pharmacy sector, with the largest pharmacy chain by revenue merging with a key wholesaler to thousands of independent pharmacies that compete against Chemist Warehouse,” said ACCC Commissioner Stephen Ridgeway.
The ACCC’s concerns span both the retail and wholesale levels and it plans to gather input from interested parties, including rival pharmacies.
More details in today’s issue of Pharmacy Daily.
